5-(1H-1,2,4-triazol-1-yl)-1H-indole → tert-Butyl 4-((6-(5-(1H-1,2,4-triazol-1-yl)-1H-indol-1-yl)pyridin-3-yl) oxy)piperidine-1-carboxylate
反応式
Cl[C:2]1[N:7]=[CH:6][C:5]([O:8][CH:9]2[CH2:14][CH2:13][N:12]([C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[CH2:11][CH2:10]2)=[CH:4][CH:3]=1.[N:22]1([C:27]2[CH:28]=[C:29]3[C:33](=[CH:34][CH:35]=2)[NH:32][CH:31]=[CH:30]3)[CH:26]=[N:25][CH:24]=[N:23]1>>[N:22]1([C:27]2[CH:28]=[C:29]3[C:33](=[CH:34][CH:35]=2)[N:32]([C:2]2[N:7]=[CH:6][C:5]([O:8][CH:9]4[CH2:14][CH2:13][N:12]([C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[CH2:11][CH2:10]4)=[CH:4][CH:3]=2)[CH:31]=[CH:30]3)[CH:26]=[N:25][CH:24]=[N:23]1参加物
3
実験手順
The title compound was prepared by following the similar procedure as described in Example-1 using tert-butyl 4-((6-chloropyridin-3-yl)oxy)piperidine-1-carboxylate (intermediate-6) and 5-(1H-1,2,4-triazol-1-yl)-1H-indole (intermediate 58) (0.440 g, 29%).
出典と根拠
- ORDレコード
- ord-cfa06b826fc049efb0ea44d1d9aa7392
- 出典データセット
- uspto-grants-2015_04
- 特許番号
- US09000175B2
反応ノート
読み込み中…